Literature DB >> 16426923

Splenic small B-cell lymphoma with IGH/BCL3 translocation.

Lorinda A Soma1, Susanne M Gollin, Ellen D Remstein, Rhett P Ketterling, Heather C Flynn, Kiran K Rajasenan, Steven H Swerdlow.   

Abstract

Isolated chromosomal translocations are important defining features of many non-Hodgkin lymphomas, especially of B-cell type. In contrast to some other translocations, the significance of IGH/BCL3 translocations is not well defined. Although often considered a feature of the ill-defined entity atypical chronic lymphocytic leukemia, very few cases are reported in which involvement of BCL3 and the precise B-cell neoplasm are both well documented. For this reason, we report a splenic-based CD5(-), CD10(-), CD43(-), CD23(-), CD103(-), FMC7(+), CD25(+) small B-cell lymphoma associated with epithelioid histiocyte clusters and a t(14;19)(q32;q13) representing an IGH/BCL3 translocation based on classical cytogenetic studies, chromosomal painting, and fluorescence in situ hybridization studies. The previously reported neoplasms with t(14;19)(q32;q13) or IGH/BCL3 translocations are also reviewed. The present case did not fall into any of the classic B-cell lymphoma categories and clearly did not represent chronic lymphocytic leukemia/small lymphocytic lymphoma. This case suggests that the IGH/BCL3 translocation may help to define a new clinicopathologic entity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426923     DOI: 10.1016/j.humpath.2005.09.025

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  The oncoprotein and transcriptional regulator Bcl-3 governs plasticity and pathogenicity of autoimmune T cells.

Authors:  Wanhu Tang; Hongshan Wang; Estefania Claudio; Ilaria Tassi; Hye-lin Ha; Sun Saret; Ulrich Siebenlist
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Defining the borders of splenic marginal zone lymphoma: a multiparameter study.

Authors:  Scott D Dufresne; Raymond E Felgar; Rachel L Sargent; Urvashi Surti; Susanne M Gollin; Ellen D McPhail; James R Cook; Steven H Swerdlow
Journal:  Hum Pathol       Date:  2009-12-11       Impact factor: 3.466

3.  Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia.

Authors:  Roman Alpatov; Billie Carstens; Kimberly Harding; Carolyn Jarrett; Sudabeh Balakhani; Jessica Lincoln; Peter Brzeskiewicz; Yu Guo; Alex Ohene-Mobley; Jamie LeRoux; Veronica McDaniel; Lynne Meltesen; Diane Minka; Mahendra Patel; Cyrus Manavi; Karen Swisshelm
Journal:  Mol Cytogenet       Date:  2015-12-30       Impact factor: 2.009

4.  Case Report: Chronic Lymphocytic Leukemia With a Rare Translocation t(14;19)(q32;q13) Involving IGH/BCL3 Rearrangements: Report of Three Chinese Cases and Literature Review.

Authors:  Qinlu Li; Shugang Xing; Heng Zhang; Xia Mao; Min Xiao; Jia Wei; Ying Wang
Journal:  Front Oncol       Date:  2020-11-19       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.